台股 » 個股 » 智基 » 籌碼相關 » 券商分點績效

智基

(6294)
可現股當沖
  • 股價
    102.5
  • 漲跌
    --
  • 漲幅
    0.00%
  • 成交量
    33
  • 產業
    上櫃 文化創意指數
  • 106人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
智基 (6294)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/04/25 ~ 2024/05/02     後一日»

券商獲利排行 - 2024/04/25 ~ 2024/05/02

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  12.49%292.50292.5-20020117.10117.1102.5
  11.51%270.50.1270.5-18220117.5117.5117.5102.5
  12.80%180.50180.5-11012117.5117.5117.5102.5
  12.62%1480148-10010117.30117.3102.5
  13.01%92092-606117.80117.8102.5
  8.33%88-0.788.7-639117.3117.5117.3102.5
  9.38%77.40.377.1-427117.9117.7117.9102.5
  12.77%75075-505117.50117.5102.5
  13.14%62062-4041180118102.5
  10.29%60.50.160.4-415117.6117.5117.6102.5
  13.14%46.5046.5-3031180118102.5
  12.81%45.2045.2-303117.60117.6102.5
  12.77%45045-303117.50117.5102.5
  12.77%45045-303117.50117.5102.5
  13.50%32032-202118.50118.5102.5
  13.14%31031-102118117.9118102.5
  13.14%31031-2021180118102.5
  13.14%31031-2021180118102.5
  13.14%31031-2021180118102.5
  13.14%31031-2021180118102.5
  12.95%30.5030.5-202117.80117.8102.5
  1.82%30-0.930.9-21214118118117.9102.5
  12.77%30030-202117.50117.5102.5
  12.77%30030-202117.5118.5117.5102.5
  12.77%30030-202117.50117.5102.5
  12.77%30030-202117.5117.5117.5102.5
  12.77%30030-202117.50117.5102.5
  12.77%30030-202117.50117.5102.5
  12.77%30030-202117.50117.5102.5
  12.77%30030-202117.50117.5102.5
  12.77%30030-202117.50117.5102.5
  3.72%17.51.915.6-134117.9117.5118.1102.5
  13.50%16016-101118.50118.5102.5
  13.50%16016-101118.50118.5102.5
  13.50%16016-101118.50118.5102.5
  6.79%160.515.5-112117.9117.5118102.5
  13.50%16016-101118.50118.5102.5
  6.74%15.80.615.3012117.5117.2117.8102.5
  13.26%15.7015.7-101118.20118.2102.5
  13.14%15.5015.5-1011180118102.5
  13.14%15.5015.5001118118118102.5
  13.14%15.5015.5-1011180118102.5
  13.14%15.5015.5-1011180118102.5
  13.14%15.5015.5-1011180118102.5
  13.14%15.5015.5-1011180118102.5
  13.14%15.5015.5-1011180118102.5
  13.14%15.5015.5-1011180118102.5
  13.14%15.5015.5-1011180118102.5
  13.14%15.5015.5-1011180118102.5
  13.14%15.5015.5-1011180118102.5

券商虧損排行 - 2024/04/25 ~ 2024/05/02

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -12.00%-281.50.2-281.719201117.3117.3117.5102.5
  -13.34%-173.50-173.511110118.3118.30102.5
  -12.73%-149.50-149.510100117.5117.50102.5
  -12.65%-148.50-148.59100117.4117.4117.5102.5
  -13.14%-139.50-139.59901181180102.5
  -13.04%-1230-123880117.9117.90102.5
  -9.20%-1191.4-120.48113117.6117.5118102.5
  -12.77%-1050-105770117.5117.50102.5
  -12.77%-1050-105770117.5117.50102.5
  -12.83%-90.50-90.5660117.6117.60102.5
  -9.52%-78.5-1.4-77.1572117.8117.9117.3102.5
  -12.54%-73.50-73.5550117.2117.20102.5
  -13.14%-620-624401181180102.5
  -10.34%-610.6-61.6351118117.9118.5102.5
  -12.86%-60.50-60.5440117.6117.60102.5
  -12.86%-60.50-60.5340117.6117.6117.1102.5
  -4.08%-57.62.8-60.44128117.7117.6117.9102.5
  -13.01%-460-46330117.8117.80102.5
  -13.50%-320-32220118.5118.50102.5
  -13.14%-310-312201181180102.5
  -13.14%-310-312201181180102.5
  -12.77%-300-30220117.5117.50102.5
  -12.77%-300-30220117.5117.50102.5
  -12.39%-290-292201171170102.5
  -6.79%-16-0.5-15.5121117.8118117.5102.5
  -13.50%-160-16110118.5118.50102.5
  -13.14%-15.50-15.51101181180102.5
  -13.14%-15.50-15.51101181180102.5
  -13.14%-15.50-15.51101181180102.5
  -13.14%-15.50-15.51101181180102.5
  -13.14%-15.50-15.51101181180102.5
  -13.14%-15.50-15.51101181180102.5
  -13.14%-15.50-15.51101181180102.5
  -13.14%-15.50-15.51101181180102.5
  -13.14%-15.50-15.51101181180102.5
  -13.14%-15.50-15.51101181180102.5
  -13.14%-15.50-15.51101181180102.5
  -13.10%-15.50-15.51101181180102.5
  -12.79%-150-15110117.5117.50102.5
  -12.77%-150-15110117.5117.5118.3102.5
  -12.77%-150-15110117.5117.50102.5
  -12.77%-150-15110117.5117.50102.5
  -12.77%-150-15110117.5117.50102.5
  -12.77%-150-15110117.5117.50102.5
  -12.77%-150-15110117.5117.50102.5
  -12.77%-150-15110117.5117.50102.5
  -6.38%-150-15121117.5117.5117.5102.5
  -12.77%-150-15110117.5117.50102.5
  -12.77%-150-15110117.5117.50102.5
  -12.77%-150-15110117.5117.50102.5
慧智基因前列腺癌基因檢測套組 推行至國內千名患者Anue鉅亨-2021/09/14
疫情推升醫材需求強 雃博5月營收創同期高 慧智基因寫新猷Anue鉅亨-2021/06/10
智基 相關文章
智基 相關影音